In the past decade there has been significant interest in studying the expression of our genetic code down to the level of single cells, to identify the functions and activities of any cell through ...

After a person survives a heart attack, the heart has a brief window of time in which it can heal if the right circumstances ...

The scientific poster, titled “ RNA Sequencing to Help Identify Rare Genetic Disorders, ” explores the diagnostic value of leveraging RNA sequencing data to reclassify variants of uncertain ...

The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...

Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...

Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, emerges from stealth today and announces that the U.S. Food and Drug Administration ...

The global Live Cell RNA Detection Market is set for robust expansion, with valuation projected to rise from USD 3.4 billion ...

A new study suggests an enzyme unique to Homo sapiens may have made us more competitive water seekers than our closest ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...